or Try an Advanced Search...

    Technical Analysis for CDT - Conduit Pharmaceuticals Inc.

    Grade Last Price % Change Price Change
    F 0.09 0.22% 0.00
    CDT closed up 0.22 percent on Wednesday, November 20, 2024, on 34 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical CDT trend table...
    Date Alert Name Type % Chg
    MACD Bullish Signal Line Cross Bullish 0.00%
    NR7 Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Up 3 Days in a Row Strength 0.00%
    Pocket Pivot Bullish Swing Setup 0.22%
    Outside Day Range Expansion 0.22%
    Wide Bands Range Expansion 0.22%
    Gapped Down Weakness 0.22%
    Older End-of-Day Signals for CDT ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakdown about 16 hours ago
    Possible NR7 about 18 hours ago
    Possible Inside Day about 18 hours ago
    Down 1% about 18 hours ago
    Up 5% about 19 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    CDT Chart by TradingView
    Basic chart:

    Profile

    • Earnings date: Unknown
    Conduit Pharmaceuticals Limited operates as a clinical stage specialty biopharmaceutical company that provides unmet medical needs in the areas of autoimmune disease and idiopathic male infertility. The company was incorporated in 2022 and is based in Grand Cayman, Cayman Islands.Conduit Pharmaceuticals Limited operates as a subsidiary of Corvus Capital Limited.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Autoimmune Disease Tax Investigation Stage Specialty Biopharmaceutical

    Is CDT a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 19 Conduit Pharmaceuticals Announces Appointment of Simon Fry to Board of Directors
    Nov 11 Why Revelation Biosciences Shares Are Trading Higher By Around 49%; Here Are 20 Stocks Moving Premarket
    Nov 5 Conduit Pharmaceuticals announces new addition to autoimmune pipeline
    Nov 4 Conduit Pharmaceuticals Announces New Addition to its Autoimmune Pipeline
    Nov 1 Conduit Pharmaceuticals announces debt restructuring and additional notes
    Nov 1 Conduit Pharmaceuticals Announces Debt Restructuring and Additional Notes
    Oct 24 Conduit Pharmaceuticals files $100M mixed securities shelf
    Oct 3 Why Levi Strauss Shares Are Trading Lower By Over 10%; Here Are 20 Stocks Moving Premarket
    Sep 3 Why Zhibao Technology Shares Are Trading Higher By Around 19%; Here Are 20 Stocks Moving Premarket
    Aug 28 Conduit Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference
    See more CDT news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 7.8
    52 Week Low 0.0789
    Average Volume 14,791,139
    200-Day Moving Average 1.51
    50-Day Moving Average 0.11
    20-Day Moving Average 0.10
    10-Day Moving Average 0.10
    Average True Range 0.01
    RSI (14) 43.50
    ADX 13.19
    +DI 24.23
    -DI 21.31
    Chandelier Exit (Long, 3 ATRs) 0.10
    Chandelier Exit (Short, 3 ATRs) 0.12
    Upper Bollinger Bands 0.12
    Lower Bollinger Band 0.08
    Percent B (%b) 0.29
    BandWidth 35.87
    MACD Line -0.01
    MACD Signal Line -0.01
    MACD Histogram 0.0001
    Fundamentals Value
    Market Cap 6.81 Million
    Num Shares 73.8 Million
    EPS -0.07
    Price-to-Earnings (P/E) Ratio -1.32
    Price-to-Sales 0.00
    Price-to-Book 0.00
    Dividend 0.00
    Dividend Yield 0.00%
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.10
    Resistance 3 (R3) 0.10 0.10 0.10
    Resistance 2 (R2) 0.10 0.10 0.10 0.10
    Resistance 1 (R1) 0.10 0.10 0.10 0.10 0.10
    Pivot Point 0.09 0.09 0.09 0.09 0.09
    Support 1 (S1) 0.09 0.09 0.09 0.09 0.09
    Support 2 (S2) 0.09 0.09 0.09 0.08
    Support 3 (S3) 0.08 0.09 0.08
    Support 4 (S4) 0.08